article thumbnail

To help solve patient distrust in pharma, industry collaboration is key

pharmaphorum

Only 33% of the UK public would trust pharmaceutical companies to keep their health data secure – whilst, for instance, 89% trust information from traditional healthcare providers – such as doctors and hospitals. He has worked on various pharmaceutical projects including technology strategy for vaccines and new growth models.

article thumbnail

The 20 Key Moments in the 340B Program's 30-Year History

Omnicell

Interestingly, the 340B law was actually included in a veterans healthcare bill (the Veterans Health Care Act) that also established a separate drug pricing program for veterans hospitals. It also raised the DSH payment cap for some rural and small urban hospitals to 12%. 2006: Congress passed, and President George W.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

AI implementation for pharma and healthcare

pharmaphorum

Abid Rahman from Intouch Group tells pharmaphorum how AI-based technology is solving challenges across healthcare systems, pharmaceutical companies, and patient treatment. We can put AI use cases in three buckets – healthcare and hospital systems, pharmaceutical companies and patient and caregivers.”.

article thumbnail

2022 ISPE Annual Meeting: Transform, Collaborate, & Innovate for the Path Forward

ISPE

Applying what has been learned over the last three years to update pharmaceutical companies’ approaches to development and implementation is key as the industry crafts its strategies in an increasingly digital and global environment. Vice President, Hospital Business Unit Global Supply Chain. Leading through Uncertainty.

article thumbnail

What HCPs think about COVID-19’s impact on cancer

pharmaphorum

Knowing the “why” can help to address the specific challenges that hospitals are facing to ensure patients are receiving the care they need. Using Sermo RealTime, we asked physicians to rank why they believe there has been a decrease in diagnosis at their hospital or practice. — Marina Garassino (@marinagarassino) May 1, 2020.

Hospitals 123
article thumbnail

KOLs in pharma: Experts who shape the drug industry

Viseven

Key Opinion Leaders play a critical role in the life sciences industry – pharmaceutical companies often engage them during clinical trials and drug commercialization. It’s a quantitative way to locate physicians leaders who influence the medical community. KOL engagement in pharma.

article thumbnail

Navigating Life Sciences Construction in California

ISPE

California's prominence in the medical realm extends to its abundance of exceptional hospitals and ground-breaking medical treatments often unparalleled elsewhere, further enhancing its appeal for various endeavors. This issue was resolved using communication methods and reprogramming strategies from the TI and core and shell sides.